GlassScriptPhysician profile
Ali Shah
NPI 1174722268
$889.85
in general payments reported to CMS, 2019-2025
12 companies · $19.42 in 2025
The $19.42 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $386 · 2022: $232 · 2023: $163 · 2024: $89.01 · 2025: $19.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $209.99 | 2021-2025 | General - Io Ablation |
| Vertos Medical, INC. | $198.82 | 2021-2023 | Mild Device Kit |
| Abbvie INC. | $142.59 | 2021-2022 | |
| Spr Therapeutics, INC | $78.00 | 2022 | |
| Si-Bone, INC. | $56.01 | 2022-2024 | |
| Allergan, INC. | $43.09 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.72 | 2022 | |
| Medtronic, INC. | $33.48 | 2024 | Intellis Adaptivestim |
| Sanofi-Aventis U.S. LLC | $24.47 | 2023 | |
| Kyowa Kirin, INC. | $24.18 | 2024 | Crysvita |
| Averitas Pharma INC. | $21.86 | 2023 | Qutenza |
| Vivus LLC | $17.64 | 2023 | Qsymia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.